Tag: Erytech
Phaxiam therapeutics (formerly erytech): Launch of a new preclinical program
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Phaxiam Therapeutics (formerly Erytech): Akkadian Partners takes legal action – 07/04/2023 at 11:06
(AOF) – The activist fund Akkadian Partners, opposed to the merger between Erytech and Pherecydes (which gave birth to Phaxiam Therapeutics), indicates that it has kept all the shares it…
Erytech Pharma merges with Pherecydes and becomes Phaxiam Therapeutics – 06/26/2023 at 10:11
(AOF) – Erytech Pharma is up 1.23% to 0.82 euro after announcing that all the resolutions for which the Board of Directors recommended a favorable vote were adopted by its…
Pherecydes Pharma/ Erytech Pharma: merger approved
(Boursier.com) — Pherecydes Pharma announces that the shareholders of Pherecydes Pharma (Pherecydes) andErytech Pharma (Erytech) have approved the merger between the two companies on the basis of a exchange parity…
ERYTECH announces the approval of the merger with Pherecydes and announces the results of the Combined General Meeting of June 23, 2023 – 06/23/2023 at 10:30 p.m.
ERYTECH announces the approval of the merger with Pherecydes and communicates the results of the Combined General Meeting of June 23, 2023 All resolutions were passed by a large majority…
ERYTECH announces the approval of the merger with Pherecydes and announces the results of the Combined General Meeting of June 23, 2023 – 06/23/2023 at 10:30 p.m.
ERYTECH announces the approval of the merger with Pherecydes and communicates the results of the Combined General Meeting of June 23, 2023 All resolutions were passed by a large majority…
Erytech: Akkadian does not intend to participate in the GA
(CercleFinance.com) – Akkadian said Thursday that he did not intend to participate in Erytech’s general meeting to be held tomorrow to allow shareholders to vote on the proposed merger with…
ERYTECH announces that Akkadian is continuing its destabilization attempt with the introduction of a new legal action – 06/20/2023 at 22:05
PRESS RELEASE ERYTECH announces that Akkadian continues its attempt at destabilization with the introduction of a new legal action Lyon (France), June 20, 2023 – ERYTECH Pharma (Euronext Paris and…
ERYTECH announces that Akkadian is continuing its destabilization attempt with the introduction of a new legal action – 06/20/2023 at 22:05
Despite the rejection by the President of the Commercial Court of Lyon of Akkadian Partners’ request to postpone the vote of the general meeting on the proposed merger, Akkadian has…
ERYTECH announces that the commercial court has dismissed Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma – 2023-06-14 at 20:00
PRESS RELEASE ERYTECH announces that the Commercial Court has dismissed Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma Lyon (France), June 14, 2023 – 8:00 p.m.…
The Commercial Court rejects Akkadian’s request to postpone the vote on the merger: the shareholders of Pherecydes and Erytech will be able to vote on the merger on June 23, 2023 – 06/14/2023 at 20:00
Nantes, June 14, 2023 – 8 p.m. CEST – Pherecydes Pharma (FR0011651694 – ALPHE), a biotechnology company specializing in precision phage therapy intended to treat resistant and/or complicated bacterial infections,…
ERYTECH announces that the commercial court has dismissed Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma – 2023-06-14 at 20:00
Lyon (France), June 14, 2023 – ERYTECH Pharma (Euronext Paris and Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drugs in red blood cells, today announces that…